BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
2 | 402.65 | 404.80 | 1 |
5 | 401.05 | 404.85 | 45 |
4 | 401.00 | 404.90 | 50 |
30 | 400.50 | 406.00 | 250 |
45 | 400.05 | 406.50 | 80 |
0 | Total | Total | 0 |
As on 03 Feb, 2023 | 04:01
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
2 | 402.65 | 404.80 | 1 |
5 | 401.05 | 404.85 | 45 |
4 | 401.00 | 404.90 | 50 |
30 | 400.50 | 406.00 | 250 |
45 | 400.05 | 406.50 | 80 |
0 | Total | Total | 0 |
As on --
(OI , PRICE )
As on --
Stock with medium financial performance and average valuation, but technica
Open | 410.65 |
Previous Close | 410.05 |
Volume | 1,462,669.00 |
Value (Lacs) | 5,912.11 |
VWAP | 402.63 |
Beta |
High | 411.80 |
Low | 397.20 |
UC Limit | 451.05 |
LC Limit | 369.05 |
52 Week High | 727.95 |
52 Week Low | 397.20 |
TTM EPS See historical trend | 36.03 (-26.53% YoY) |
TTM PE See historical trend | 11.22 (Average PE) |
P/B See historical trend | 0.97 |
Face Value | 1.00 |
Mkt Cap (Rs. Cr.) | 23,684 |
Dividend Yield | 2.23 |
20D Avg Volume | 1,346,865 |
20D Avg Delivery(%) | 45.36 |
Sector PE | 27.21 |
Book Value Per Share | 419.40 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection Jan 04 2023 01:01 PM
Tergene Biotech gets recommendation from CDSCO subject expert committee for pneumococcal 15-valent vaccine Dec 27 2022 01:12 PM
Performance of sectoral indices in 2022: There's more bad than good Dec 27 2022 11:12 AM
MF stakes in November public issues exceed funds deployed in secondary markets Dec 15 2022 11:12 AM
Qty 297308 | Price 489.3 | % Traded 0.05 |
Qty 297308 | Price 489.3 | % Traded 0.05 |
Qty 297309 | Price 557.3 | % Traded 0.05 |
Qty 297309 | Price 557.3 | % Traded 0.05 |
Qty 277213 | Price 524.5 | % Traded 0.05 |
Qty 277213 | Price 524.5 | % Traded 0.05 |
Qty 435602 | Price 514.05 | % Traded 0.07 |
Qty 435602 | Price 514.05 | % Traded 0.07 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 8660510 | Price 849.3 | % Traded 1.48 |
Qty 2360231 | Price 875.94 | % Traded 0.40 |
Qty 1475687 | Price 670.51 | % Traded 0.25 |
Qty 1732500 | Price 669.92 | % Traded 0.30 |
Qty 1940000 | Price 180.97 | % Traded 0.33 |
Qty 1500000 | Price 172.99 | % Traded 0.26 |
Qty 2353228 | Price 173.03 | % Traded 0.40 |
Qty 375750 | Price 1037.53 | % Traded 0.06 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Qty 450000 | Price 444.7 | % Traded 0.08 | Post Tnx Hold. 3.49% |
Qty 3730000 | Price 454 | % Traded 0.64 | Post Tnx Hold. 33.51% |
Qty 1000000 | Price 533.45 | % Traded 0.17 | Post Tnx Hold. 4.33% |
Qty 20000 | Price 550.5 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 5000 | Price 550 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 900000 | Price 559.45 | % Traded 0.15 | Post Tnx Hold. 3.49% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
Qty 79000 | Price 0 | % Traded 0.00 | Post Tnx Hold. 5.01% |
Qty 130000 | Price 0 | % Traded 0.02 | Post Tnx Hold. 0.02% |
Qty 130000 | Price 0 | % Traded 0.02 | Post Tnx Hold. 0% |
Qty 11892836 | Price 0 | % Traded 2.03 | Post Tnx Hold. 3.08% |
Qty 600000 | Price 0 | % Traded 0.10 | Post Tnx Hold. 1.19% |
Qty 11774855 | Price 0 | % Traded 2.01 | Post Tnx Hold. 5.11% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharm | 404.20 | -1.43 | 23,683.64 | 11.22 | 0.96 | 10.77 | -39.74 | 2,678 | 23,455 | 0.10 |
Sun Pharma | 1,028.15 | 2.04 | 246,687.62 | 58.58 | 4.83 | 6.81 | 16.37 | 3,405 | 38,654 | 0.02 |
Cipla | 1,022.30 | -0.29 | 82,514.32 | 31.27 | 3.91 | 12.07 | 7.30 | 2,559 | 21,763 | 0.04 |
Divis Labs | 2,884.35 | -11.71 | 76,570.43 | 25.59 | 6.53 | 25.24 | -32.33 | 2,960 | 8,959 | 0.00 |
Dr Reddys Labs | 4,358.35 | -0.27 | 72,576.83 | 19.92 | 3.78 | 11.35 | -0.37 | 2,112 | 21,545 | 0.16 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>